Arcturus Therapeutics Holdings

-$2.00 (-8.52%) Today
$0.00 (0.00%) As of 11:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARCT and other ETFs, options, and stocks.

About ARCT

Arcturus Therapeutics Holdings, Inc. is a clinical-stage mRNA medicines and vaccines company, which focuses on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF.

CEO
Joseph E. Payne
Employees
118
Headquarters
San Diego, California
Founded
2013

ARCT Key Statistics

Market cap
566.22M
Price-Earnings ratio
—
Dividend yield
—
Average volume
609.31K
High today
$24.00
Low today
$21.10
Open price
$23.83
Volume
522.81K
52 Week high
$89.18
52 Week low
$21.02

ARCT News

BenzingaJan 24

Arcturus Therapeutics' COVID-19 Booster Clinical Trial Show Encouraging Neutralizing Antibody Responses

In this article: Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) has announced updated data Phase 1/2 booster trial of ARCT-154 and ARCT-165, its investigati

ARCT Earnings

-$2.15
-$1.43
-$0.72
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 28, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure